Skip to main content

Melanotan II vs Gonadorelin

Both Melanotan II and Gonadorelin are used for sexual-health. Here's how their evidence, dosing, and regulatory status actually compare.

Melanotan II

Evidence C+

Melanotan II (MT-II)

A non-selective melanocortin agonist (MC1R/MC3R/MC4R) that produces tanning and erection effects. Significant safety concerns including melanoma case reports.

View full Melanotan II profile →

Gonadorelin

Evidence A

Gonadorelin (GnRH)

Synthetic GnRH used clinically to stimulate LH/FSH release. In testosterone replacement therapy, used pulsatile to preserve testicular size and fertility instead of hCG.

View full Gonadorelin profile →

Side-by-Side

AttributeMelanotan IIGonadorelin
Evidence GradeC+A
FDA StatusNot FDA-approved — sold illegally as cosmetic; FDA warning letters issuedFDA-approved (Factrel) historically for diagnostic GnRH stimulation; off-label use in TRT to preserve testicular function
Typical Dose0.25–1 mg daily during loading, then maintenance (subcutaneous)100–500 mcg every 1–3 days (subcutaneous, pulsatile)
Clinics Indexed18156
Categoriesskin, sexual-healthsexual-health, fertility

Key reported benefits — Melanotan II

  • UV-independent tanning
  • Erectile effect (off-label)

Key reported benefits — Gonadorelin

  • LH/FSH stimulation
  • Testicular preservation on TRT
  • Fertility support

Educational use only

This comparison is for educational purposes and not medical advice. Peptide selection should be made with a licensed medical professional based on your individual goals, health history, and current evidence quality.

← Back to all comparisons